Quest Partners LLC Agios Pharmaceuticals, Inc. Transaction History
Quest Partners LLC
- $1.12 Trillion
- Q3 2024
A detailed history of Quest Partners LLC transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 2,202 shares of AGIO stock, worth $121,286. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,202
Previous 919
139.61%
Holding current value
$121,286
Previous $39.6 Million
146.89%
% of portfolio
0.01%
Previous 0.01%
Shares
3 transactions
Others Institutions Holding AGIO
# of Institutions
226Shares Held
55.6MCall Options Held
275KPut Options Held
251K-
Farallon Capital Management LLC San Francisco, CA5.65MShares$311 Million1.18% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.5MShares$303 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$268 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.88MShares$214 Million2.8% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD2.78MShares$153 Million0.01% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $3.02B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...